These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 21567107)

  • 41. Isolated limb perfusion: a novel delivery system for wild-type p53 and fiber-modified oncolytic adenoviruses to extremity sarcoma.
    Hannay J; Davis JJ; Yu D; Liu J; Fang B; Pollock RE; Lev D
    Gene Ther; 2007 Apr; 14(8):671-81. PubMed ID: 17287860
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
    Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
    J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oncolytic capacity of attenuated replicative semliki forest virus in human melanoma xenografts in severe combined immunodeficient mice.
    Vähä-Koskela MJ; Kallio JP; Jansson LC; Heikkilä JE; Zakhartchenko VA; Kallajoki MA; Kähäri VM; Hinkkanen AE
    Cancer Res; 2006 Jul; 66(14):7185-94. PubMed ID: 16849565
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Oncolytic Semliki forest virus vector as a novel candidate against unresectable osteosarcoma.
    Ketola A; Hinkkanen A; Yongabi F; Furu P; Määttä AM; Liimatainen T; Pirinen R; Björn M; Hakkarainen T; Mäkinen K; Wahlfors J; Pellinen R
    Cancer Res; 2008 Oct; 68(20):8342-50. PubMed ID: 18922906
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters.
    Ebara S; Shimura S; Nasu Y; Kaku H; Kumon H; Yang G; Wang J; Timme TL; Aguilar-Cordova E; Thompson TC
    Prostate Cancer Prostatic Dis; 2002; 5(4):316-25. PubMed ID: 12627218
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Oncolytic virus therapy for pancreatic cancer using the adenovirus library displaying random peptides on the fiber knob.
    Nishimoto T; Yoshida K; Miura Y; Kobayashi A; Hara H; Ohnami S; Kurisu K; Yoshida T; Aoki K
    Gene Ther; 2009 May; 16(5):669-80. PubMed ID: 19225547
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Utility of TK/GCV in the context of highly effective oncolysis mediated by a serotype 3 receptor targeted oncolytic adenovirus.
    Raki M; Hakkarainen T; Bauerschmitz GJ; Särkioja M; Desmond RA; Kanerva A; Hemminki A
    Gene Ther; 2007 Oct; 14(19):1380-8. PubMed ID: 17611584
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Oncolytic herpes simplex virus engineering and preparation.
    Agarwalla PK; Aghi MK
    Methods Mol Biol; 2012; 797():1-19. PubMed ID: 21948465
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synergy between expression of fusogenic membrane proteins, chemotherapy and facultative virotherapy in colorectal cancer.
    Hoffmann D; Bangen JM; Bayer W; Wildner O
    Gene Ther; 2006 Nov; 13(21):1534-44. PubMed ID: 16791286
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Human prostate carcinoma cells as targets for herpes simplex virus thymidine kinase-mediated suicide gene therapy.
    Loimas S; Toppinen MR; Visakorpi T; Jänne J; Wahlfors J
    Cancer Gene Ther; 2001 Feb; 8(2):137-44. PubMed ID: 11263529
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibition of NF-kappaB enhances the cytotoxicity of virus-directed enzyme prodrug therapy and oncolytic adenovirus cancer gene therapy.
    Palmer DH; Chen MJ; Searle PF; Kerr DJ; Young LS
    Gene Ther; 2005 Aug; 12(15):1187-97. PubMed ID: 15800660
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Switching a replication-defective adenoviral vector into a replication-competent, oncolytic adenovirus.
    Nakashima H; Chiocca EA
    J Virol; 2014 Jan; 88(1):345-53. PubMed ID: 24155386
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [A novel packaging system of recombinant AAV5/5 vector].
    Dong X; Tian W; Yuan Z; Tan S; Wu X
    Sheng Wu Gong Cheng Xue Bao; 2010 May; 26(5):679-86. PubMed ID: 20684314
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effective treatment of human breast tumor in a mouse xenograft model with herpes simplex virus type 1 specifying the NV1020 genomic deletion and the gBsyn3 syncytial mutation enabling high viral replication and spread in breast cancer cells.
    Israyelyan AH; Melancon JM; Lomax LG; Sehgal I; Leuschner C; Kearney MT; Chouljenko VN; Baghian A; Kousoulas KG
    Hum Gene Ther; 2007 May; 18(5):457-73. PubMed ID: 17536976
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Degradation of fibrillar collagen in a human melanoma xenograft improves the efficacy of an oncolytic herpes simplex virus vector.
    McKee TD; Grandi P; Mok W; Alexandrakis G; Insin N; Zimmer JP; Bawendi MG; Boucher Y; Breakefield XO; Jain RK
    Cancer Res; 2006 Mar; 66(5):2509-13. PubMed ID: 16510565
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of the T-REx transcription switch for conditional expression and regulation of HSV-1 vectors.
    Knopf CW; Zavidij O; Rezuchova I; Rajcáni J
    Virus Genes; 2008 Feb; 36(1):55-66. PubMed ID: 18193347
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Flip-Flop HSV-BAC: bacterial artificial chromosome based system for rapid generation of recombinant herpes simplex virus vectors using two independent site-specific recombinases.
    Kuroda T; Martuza RL; Todo T; Rabkin SD
    BMC Biotechnol; 2006 Sep; 6():40. PubMed ID: 16995942
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Safety of non-replicative and oncolytic replication-selective HSV vectors.
    Epstein AL; Rabkin SD
    Trends Mol Med; 2024 Aug; 30(8):781-794. PubMed ID: 38886138
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Imaging and therapy of malignant pleural mesothelioma using replication-competent herpes simplex viruses.
    Adusumilli PS; Stiles BM; Chan MK; Mullerad M; Eisenberg DP; Ben-Porat L; Huq R; Rusch VW; Fong Y
    J Gene Med; 2006 May; 8(5):603-15. PubMed ID: 16475242
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficient Strategy for Synthesizing Vector-Free and Oncolytic Herpes Simplex Type 1 Viruses.
    Xiao H; Hu H; Guo Y; Li J; Zeng WB; Luo MH; Wang M; Hu Z
    ACS Synth Biol; 2024 Oct; 13(10):3268-3280. PubMed ID: 39358309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.